Compounded semaglutide, delivered to you.
Prescribed online by licensed providers. Prepared by US-licensed 503A compounding pharmacies. Free shipping to all 50 states. Starting at $149/month. Compounded medications are not FDA-approved.
Compounded semaglutide is a preparation of the same active molecule as brand-name Ozempic (type 2 diabetes) and Wegovy (weight management) — a GLP-1 receptor agonist that reduces appetite and slows gastric emptying. It is prepared by a US-licensed 503A compounding pharmacy under a valid patient-specific prescription. Compounded semaglutide is NOT FDA-approved and is NOT therapeutically equivalent to the brand-name products. Ondra Health connects patients in all 50 US states with licensed providers at Wasef Health, PC, who evaluate each patient and, when clinically appropriate, write a patient-specific prescription. Pricing starts at $149/month. The STEP 1 trial (Wilding et al., NEJM 2021) reported approximately 14.9% mean weight loss over 68 weeks with brand-name semaglutide at 2.4mg — compounded versions have not been independently evaluated at trial scale and individual results vary.
The Process
How Ondra Health works
Four steps from intake to doorstep. No in-person visits, no waiting rooms.
3-minute online intake covering your health history and goals. Select your preferred pharmacy and formulation.
A licensed provider at Wasef Health, PC reviews your intake within 24 hours and determines clinical suitability.
If appropriate, your provider issues a patient-specific prescription with your starting dose and titration schedule.
Ships from a US-licensed 503A compounding pharmacy within 2–3 business days. Free shipping to all 50 states.
Pricing
Transparent, flat-rate pricing
One price across all titration doses — cost does not increase as you move up in dose. Includes medication and free shipping.
New user starter pack: $249 · Regular: $339
Only charged if a provider approves treatment
Questions & Answers
Common questions about compounded semaglutide
Answers sourced from the FDA, NEJM, and federal compounding law. Last reviewed June 2026.
What is compounded semaglutide?
Compounded semaglutide is a preparation of the same active molecule as brand-name Ozempic and Wegovy — a GLP-1 receptor agonist. Prepared by a US-licensed 503A compounding pharmacy under a valid patient-specific prescription. Not FDA-approved and not therapeutically equivalent to the branded products.
How much does compounded semaglutide cost?
At Ondra Health, compounded semaglutide starts at $149/month (monthly billing) or $113/month on a quarterly plan ($339 billed every 3 months). Pricing is flat across all titration doses — cost does not increase as you move up. New GLP-1 users qualify for the starter pack at $249 for the first quarter.
Is compounded semaglutide legal in 2026?
Yes — compounded semaglutide remains legal through 503A compounding pharmacies in 2026 under a valid patient-specific prescription with documented individual clinical justification. The FDA's enforcement discretion for widespread compounding ended April 22, 2025. 503B outsourcing facilities may no longer legally compound semaglutide. Ondra Health works exclusively with 503A pharmacy partners.
Source: FDAWhat did the STEP 1 trial show about semaglutide?
The STEP 1 trial (Wilding et al., NEJM Feb 2021) studied 1,961 adults without diabetes over 68 weeks. Participants on 2.4mg weekly brand-name semaglutide achieved a mean weight loss of 14.9% vs 2.4% placebo. 86.4% achieved ≥5% weight loss. This data reflects FDA-approved Wegovy, not compounded semaglutide. Individual results vary.
Source: NEJMWhat is the starting dose for semaglutide?
The standard starting dose is 0.25mg weekly for the first 4 weeks, then 0.5mg, 1mg, 1.7mg, and 2.4mg over approximately 16–20 weeks. Your provider sets your personal titration schedule based on tolerability and response. At Ondra Health, pricing is flat — the same cost applies at every dose level.
How is semaglutide administered?
Compounded semaglutide is administered as a weekly subcutaneous (under-skin) injection, typically into the abdomen, thigh, or upper arm. Ondra Health provides injection guidance materials and your provider can answer questions through the patient portal. No in-person clinic visits required.
What are common semaglutide side effects?
The most common side effects are nausea, vomiting, diarrhea, constipation, and reduced appetite — especially during dose increases. These are typically mild and temporary. Less common: headache, fatigue, injection site reactions. Discuss your full risk profile with your Ondra provider before starting.
Which pharmacies does Ondra use for semaglutide?
Ondra Health works with three 503A pharmacy partners for semaglutide: Hallandale Pharmacy (no additives — not available in CA, KS, AR, MI, MN, AL, HI, MS, MA), Boudreaux's New Drug Store (Glycine formulation — not available in AR, CT, HI, NJ), and Vials RX (B12 + Glycine — available in all 50 states). You choose during your intake.
Pharmacy Partners
US-licensed 503A compounding pharmacies
All semaglutide is prepared by state-licensed 503A pharmacies. You select your preferred pharmacy during the intake process, subject to state availability and provider approval.
Medications: Semaglutide + Tirzepatide
Plans: Monthly · Quarterly · Maintenance
Not available in: CA, KS, AR, MI, MN, AL, HI, MS, MA
Medications: Semaglutide + Tirzepatide
Plans: Monthly · Quarterly · Maintenance
Not available in: AR, CT, HI, NJ
Medications: Semaglutide + Tirzepatide
Plans: Monthly · Quarterly · Maintenance
State restrictions: None
State Coverage
Compounded semaglutide in your state
Ondra Health has licensed provider coverage in all 50 US states. Pharmacy availability may vary. Select your state for availability details, local FAQs, and state-specific information.
Start your intake today
3-minute online intake. Licensed provider review within 24 hours. Free shipping to all 50 states if prescribed.
Start Your Intake →*Compounded semaglutide is not FDA-approved and is not therapeutically equivalent to Ozempic® or Wegovy®. Compounded medications are prepared by state-licensed 503A pharmacies under valid patient-specific prescriptions. All prescribing decisions are made solely by licensed providers at Wasef Health, PC. Pricing reflects medication cost; provider fees may apply. Clinical trial data (STEP 1) reflects brand-name semaglutide, not compounded versions. Individual results vary. Not medical advice.